Back to search

Georgia Institute of Technology

Immune Modulatory and Regenerative Effects of Ceramide Containing Hybrid Sphingosomes In Mesenchymal Stromal Cells

Abstract

dc:description.abstract

This project was an exploration into cellular fate and immune modulatory outcomes resulting from the treatment of MSCs with ceramides of different chain lengths. The future goal of this strategy is to harness the inherent anti-inflammatory and immunosuppressive properties of MSCs, and to use the ceramide containing hybrid sphingosome-killed cellular corpses to drive regeneration and immune-suppression for therapeutic applications in wound healing or graft-versus-host disease (GvHD). Neutral hybrid sphingosomes and liposomes of mean hydrodynamic diameter 100 nm were synthesized, and their formation was confirmed by electron microscopy. Lipid extracts from C6-NBD ceramide hybrid sphingosome-treated MSCs show that the ceramide is internalized and metabolized into sphingomyelin and glucosylceramide by the cells. Moreover, the extracted C6-NBD ceramide is at least 2.5 times higher in the hybrid sphingosomal C6-NBD ceramide treated groups compared to their free C6-NBD ceramide treated counterparts, for every treatment concentration used. It was shown that MSCs are able to have surface interactions and/or uptake the ceramide hybrid sphingosomes, by imaging cells treated with NBD versions of the vesicles. MSC viability was shown to decrease with increasing concentrations of C6 ceramide, with the lowest viability achieved being 46% of the untreated cells. However, such a marked trend of concentration dependent drop in viability was not observed when the cells were treated with C12 ceramide hybrid sphingosomes or ghost liposomes. MSCs treated with C6 ceramide hybrid sphingosomes showed more rounded morphology, along with detachment from the culture surface and media acidification, as a function of concentration. Caspase 3/7 levels were not observed to vary significantly with ceramide concentration when treated with any formulation. Autophagosome and autophagolysosome levels were shown to decrease with increasing concentrations of C6 ceramide. MSCs treated with sphingomyelinase, an enzyme that converts sphingomyelin to ceramide, also showed a similar trend of decreasing autophagy with increasing enzyme concentration. Hybrid sphingosome-treated MSCs were also shown to be efferocytosed by RAW 264.7 macrophages.

Degree

thesis:*
Level thesis:degree_level
Masters
Department dc:contributor.department
Biomedical Engineering (Joint GT/Emory Department)
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lal, Nidhi
Advisor dc:contributor.advisor
  • Botchwey, Edward A.
Committee members dc:contributor.committeemember
  • Arvanitis, Costas
  • Douglas-Green, Simone

Subjects

dc:subject × 7

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1853/78528

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Lal, Nidhi. Immune Modulatory and Regenerative Effects of Ceramide Containing Hybrid Sphingosomes In Mesenchymal Stromal Cells. Masters thesis, Georgia Institute of Technology, 2024. https://hdl.handle.net/1853/78528